Castle Biosciences, Inc.CSTLNASDAQ
Loading
Year-over-year earnings per share growth rate
Percentile
P10
Near historical low
vs 2Y Ago
-4.7x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -297.50% |
| Q3 2025 | -112.50% |
| Q2 2025 | 117.78% |
| Q1 2025 | -364.71% |
| Q4 2024 | 317.18% |
| Q3 2024 | -74.53% |
| Q2 2024 | 455.56% |
| Q1 2024 | 5.36% |
| Q4 2023 | 63.42% |
| Q3 2023 | 62.86% |
| Q2 2023 | 36.36% |
| Q1 2023 | -41.03% |
| Q4 2022 | -1.30% |
| Q3 2022 | -1118.35% |
| Q2 2022 | 93.48% |
| Q1 2022 | -288.00% |
| Q4 2021 | 46.81% |
| Q3 2021 | -34.29% |
| Q2 2021 | -105.88% |
| Q1 2021 | 26.09% |
| Q4 2020 | 0.00% |
| Q3 2020 | -187.50% |
| Q2 2020 | -366.67% |
| Q1 2020 | -75.00% |
| Q4 2019 | -72.09% |
| Q3 2019 | 623.75% |
| Q2 2019 | 36.85% |
| Q1 2019 | -136.11% |
| Q4 2018 | 212.50% |
| Q3 2018 | -6.67% |
| Q2 2018 | 11.76% |
| Q1 2018 | 0.00% |